Amarin Corp Plcuk (AMRN) EBT Margin (QoQ) (2013 - 2026)

Amarin Corp Plcuk (AMRN) EBT Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,760.00
Dec 31, 2025 1,461.00
Sep 30, 2025 215.00
Jun 30, 2025 1,395.00
Mar 31, 2025 -6,776.00
Dec 31, 2024 8,622.00
Sep 30, 2024 -5,518.00
Jun 30, 2024 1,960.00
Mar 31, 2024 -1,204.00
Dec 31, 2023 2,520.00
Sep 30, 2023 -613.00
Jun 30, 2023 -549.00
Mar 31, 2023 -13,032.00
Dec 31, 2022 11,778.00
Sep 30, 2022 6,429.00
Jun 30, 2022 -3,866.00
Mar 31, 2022 -4,130.00
Dec 31, 2021 2,047.00
Sep 30, 2021 -1,487.00
Jun 30, 2021 644.00